What is Flynn Life Sciences Group?
Flynn Life Sciences Group specializes in partnering with small and emerging life science companies across all development phases. They provide critical expertise in clinical operations, trial preparation, and targeted consulting services. Offering flexible support solutions, including interim leadership and full functional service provider options, Flynn aims to help clients navigate complex clinical development challenges. Their extensive network of seasoned consultants ensures clients receive timely, effective, and customized support, accelerating progress within the life sciences industry.
How much funding has Flynn Life Sciences Group raised?
Flynn Life Sciences Group has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Flynn Life Sciences Group
PPP
Public-Private Partnership
What's next for Flynn Life Sciences Group?
The substantial late-stage funding indicates Flynn Life Sciences Group is poised for significant expansion and further integration within the life sciences ecosystem. This capital infusion will likely fuel the enhancement of their consulting services, broaden their operational reach, and potentially support strategic acquisitions or partnerships. The company's focus on providing essential expertise to emerging life science firms positions them to capitalize on the sector's continued innovation and growth.
See full Flynn Life Sciences Group company page
